Patient experience with familial chylomicronemia syndrome before and after olezarsen treatment: Qualitative interviews with clinical trial participants
Open Access
- 18 June 2025
- journal article
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 19 (5) , 1243-1255
Abstract
No abstract availableKeywords
Funding Information
- Ionis Pharmaceuticals Inc
This publication has 19 references indexed in Scilit:
- Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia SyndromeNew England Journal of Medicine, 2024
- Qualitative development of the PROMIS Profile v1.0-Familial Chylomicronemia Syndrome (FCS) 28Quality of Life Research, 2022
- Characterizing familial chylomicronemia syndrome: Baseline data of the APPROACH studyJournal of Clinical Lipidology, 2018
- Informing a priori Sample Size Estimation in Qualitative Concept Elicitation Interview Studies for Clinical Outcome Assessment Instrument DevelopmentValue in Health, 2018
- Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life spanJournal of Clinical Lipidology, 2018
- The burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS studyJournal of Clinical Lipidology, 2018
- Diagnostic algorithm for familial chylomicronemia syndromeAtherosclerosis Supplements, 2017
- Chylomicronaemia—current diagnosis and future therapiesNature Reviews Endocrinology, 2015
- Hypertriglyceridemia: phenomics and genomicsMolecular and Cellular Biochemistry, 2009
- A Purposeful Approach to the Constant Comparative Method in the Analysis of Qualitative InterviewsQuality & Quantity, 2002